ea0020p220 | Endocrine tumours and neoplasia | ECE2009
Pokramovich Julia
, Dreval Alexandr
, Nechaeva Olga
, Pronin Viacheslav
, Koloda Dmitry
, Gitel Evgeny
Aim: To estimate efficiency of long acting somatostatin analog (Oktreotid-Depot, Ltd FarmSyntez, Russia) in acromegaly treatment.Material and methods: Twenty-five patients with the confirmed acromegaly diagnosis, active phase, receiving Oktreotid-Depot therapy within 612 months in a single dose of 2040 mg/month. Every three months dynamics of clinical signs, basal IGF-1 and GH levels and pituitary adenoma size were analyzed.<p...